| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 347.63B | 357.68B | 346.69B | 312.68B | 282.50B | 263.91B |
| Gross Profit | 46.50B | 55.20B | 44.63B | 43.05B | 42.02B | 38.54B |
| EBITDA | 14.51B | 20.35B | 13.05B | 14.21B | 13.57B | 13.18B |
| Net Income | 7.09B | 11.43B | 6.45B | 9.16B | 7.53B | 6.73B |
Balance Sheet | ||||||
| Total Assets | 257.97B | 314.73B | 269.73B | 245.15B | 233.96B | 236.72B |
| Cash, Cash Equivalents and Short-Term Investments | 32.99B | 33.92B | 35.72B | 26.79B | 36.05B | 67.90B |
| Total Debt | 18.78B | 52.00B | 30.60B | 21.57B | 15.59B | 32.69B |
| Total Liabilities | 121.27B | 167.81B | 131.97B | 111.08B | 106.20B | 115.25B |
| Stockholders Equity | 136.64B | 146.87B | 137.71B | 134.03B | 127.72B | 121.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -17.89B | 3.73B | -13.70B | -13.25B | -1.88B |
| Operating Cash Flow | 0.00 | -16.89B | 5.13B | -10.48B | -6.28B | 2.51B |
| Investing Cash Flow | 0.00 | -3.59B | -1.70B | -2.07B | -5.35B | -6.55B |
| Financing Cash Flow | 0.00 | 18.76B | 5.46B | 3.24B | -19.56B | -1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥146.84B | 13.90 | ― | 3.22% | 14.62% | 33.65% | |
65 Neutral | ¥109.34B | 10.97 | ― | 2.13% | 3.17% | 77.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥122.69B | 9.39 | ― | 2.89% | 16.39% | 101.50% | |
63 Neutral | ¥80.17B | 9.55 | ― | 3.63% | 20.40% | 50.00% | |
60 Neutral | ¥57.30B | 14.53 | ― | 1.57% | 4.01% | 21.41% | |
59 Neutral | ¥100.84B | 11.00 | ― | 3.13% | 10.13% | 13.31% |